.../...
Let's take a look at some of the Pfizer news that made headlines this year.
- The Mega Deal
- Cost-cutting measures in full gear
- The Neurontin Controversy
- Major legal settlements
- Not out of legal woods...
- Regulatory Approvals
- Clinical Trial Missteps and Regulatory Knockdowns
- Late-stage pipeline
- Eyeing generic drug pie
- Closing Thoughts
Artículo completo...
No hay comentarios:
Publicar un comentario